Syschem (India) Ltd
SYSCHEMSyschem (India) Ltd
SYSCHEMPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-302.21 | 2.81 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
50.26 | 6.38 | 0.53% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Syschem India is engaged in the business of manufacturing of active pharmaceutical ingredients/intermediates. It's main products/services are Solvents, and Cephalosporins & preparations
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 3.66 | 12.54 | 66.51 | 93.19 | 77.02 | 74.67 | 65.76 | 130.63 | 233.65 | 253.67 | ||||||||||
Raw Materials | 3.48 | 10.43 | 61.59 | 85.63 | 67.16 | 55.42 | 46.97 | 92.46 | 197.91 | 249.93 | ||||||||||
Power & Fuel Cost | 0.57 | 0.52 | 1.60 | 1.57 | 1.89 | 2.87 | 2.39 | 2.15 | 2.84 | |||||||||||
Employee Cost | 0.24 | 0.61 | 2.47 | 2.96 | 2.99 | 4.10 | 4.54 | 4.40 | 6.08 | |||||||||||
Selling & Administrative Expenses | 0.21 | 0.31 | 0.70 | 1.00 | 1.66 | 8.47 | 8.41 | 18.30 | 37.32 | |||||||||||
Operating & Other expenses | 0.02 | 0.72 | -2.68 | -1.63 | 3.34 | 8.72 | 2.76 | 4.42 | -17.65 | |||||||||||
EBITDA | -0.86 | -0.05 | 2.83 | 3.66 | -0.02 | -4.91 | 0.69 | 8.90 | 7.15 | 3.74 | ||||||||||
Depreciation/Amortization | 2.16 | 2.05 | 2.08 | 2.15 | 2.15 | 2.35 | 2.58 | 2.70 | 2.79 | 2.77 | ||||||||||
PBIT | -3.02 | -2.10 | 0.75 | 1.51 | -2.17 | -7.26 | -1.89 | 6.20 | 4.36 | 0.97 | ||||||||||
Interest & Other Items | 0.01 | 0.03 | 0.15 | 0.01 | 0.02 | 0.06 | 0.28 | 0.04 | 0.25 | 0.15 | ||||||||||
PBT | -3.03 | -2.13 | 0.60 | 1.50 | -2.19 | -7.32 | -2.17 | 6.16 | 4.11 | 0.82 | ||||||||||
Taxes & Other Items | -0.81 | -0.65 | 0.26 | 0.75 | -0.35 | -1.75 | -0.47 | 1.64 | 1.35 | 1.35 | ||||||||||
Net Income | -2.22 | -1.48 | 0.34 | 0.75 | -1.84 | -5.57 | -1.70 | 4.52 | 2.76 | -0.53 | ||||||||||
EPS | -0.23 | -0.16 | 0.19 | 0.39 | -0.90 | -2.54 | -0.70 | 1.50 | 0.74 | -0.13 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Syschem (India) Ltd | 58.03 | 2.81 | — |
Sun Pharmaceutical Industries Ltd | 44.98 | 6.42 | 0.75% |
Cipla Ltd | 29.13 | 4.48 | 0.87% |
Torrent Pharmaceuticals Ltd | 64.71 | 15.63 | 0.88% |
Price Comparison
Compare SYSCHEM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
SYSCHEM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Net loss of Syschem (India) reported to Rs 0.64 crore in the quarter ended September 2024 as against net profit of Rs 1.12 crore during the previous quarter ended September 2023. Sales rose 28.05% to Rs 47.52 crore in the quarter ended September 2024 as against Rs 37.11 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales47.5237.11 28 OPM %0.154.99 - PBDT0.041.82 -98 PBT-0.641.12 PL NP-0.641.12 PL Powered by Capital Market - Live
Syschem (India) will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Net profit of Syschem (India) declined 91.67% to Rs 0.14 crore in the quarter ended June 2024 as against Rs 1.68 crore during the previous quarter ended June 2023. Sales rose 103.09% to Rs 87.53 crore in the quarter ended June 2024 as against Rs 43.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales87.5343.10 103 OPM %0.935.71 - PBDT0.822.36 -65 PBT0.141.68 -92 NP0.141.68 -92 Powered by Capital Market - Live
Syschem (India) will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Stocks that will see action today: August 21, 2023
Syschem India share price gains 9% on capacity expansion plan
Syschem India Standalone March 2023 Net Sales at Rs 56.91 crore, up 152.73% Y-o-Y
Syschem India Standalone June 2021 Net Sales At Rs 19.55 Crore, Up 0% Y-o-Y
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 20.18%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.04% to 0.06%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 29.77%, vs industry avg of 15.28%